Literature DB >> 1784511

Physiological responses to maximal exercise on arm cranking and wheelchair ergometer with paraplegics.

G Martel1, L Noreau, J Jobin.   

Abstract

This study describes the responses of 20 paraplegic athletes (mean age: 26.8 +/- 1.6 years) to a continuous incremental workload test until exhaustion on an arm cranking ergometer (ACE) and on a wheelchair ergometer (WCE). Both ergometers used the same electromagnetic braking device allowing a fair comparison between results. Tests were conducted at a 24 hour interval at the same time of the day. Oxygen uptake (VO2), heart rate (HR), workload (W), blood pressure (BP), Borg index, and mechanical efficiency (ME) were measured at every minute during the effort and the cool down periods of both tests. The purpose of this study was to analyse the different responses obtained on ACE and on WCE during maximal effort by paraplegics, and also to determine which ergometer permits the higher ME. Results indicate that paraplegics reached the same max HR on ACE and on WCE (97% of the predicted max HR). The lack of significant difference (p less than 0.05) between ACE and WCE in terms of maximal values of VO2, VE and HR suggests that the subjects reached their maximal capacity on each test regardless of the type of ergometer. Nevertheless, W max (in Watts) was 26% higher on ACE than on WCE. Maximal ME values were respectively 16% and 11.6% on ACE and WCE. Results suggest that ergometers and protocol used in this study are appropriate to measure physiological responses of paraplegic athletes during arm cranking and wheelchair exercise without excessive or early arm fatigue.

Entities:  

Mesh:

Year:  1991        PMID: 1784511     DOI: 10.1038/sc.1991.61

Source DB:  PubMed          Journal:  Paraplegia        ISSN: 0031-1758


  8 in total

1.  Arm Cycling Combined with Passive Leg Cycling Enhances VO2peak in Persons with Spinal Cord Injury Above the Sixth Thoracic Vertebra.

Authors:  Tom Tørhaug; Berit Brurok; Jan Hoff; Jan Helgerud; Gunnar Leivseth
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017-11-20

Review 2.  Spinal cord injury, exercise and quality of life.

Authors:  L Noreau; R J Shephard
Journal:  Sports Med       Date:  1995-10       Impact factor: 11.136

3.  Reliability and validity of the six-minute arm test for the evaluation of cardiovascular fitness in people with spinal cord injury.

Authors:  Adrienne T Hol; Janice J Eng; William C Miller; Shannon Sproule; Andrei V Krassioukov
Journal:  Arch Phys Med Rehabil       Date:  2007-04       Impact factor: 3.966

4.  The Impact of Sub-maximal Exercise on Neuropathic Pain, Inflammation, and Affect Among Adults With Spinal Cord Injury: A Pilot Study.

Authors:  Kendra R Todd; Jan W Van Der Scheer; Jeremy J Walsh; Garett S Jackson; Gabriel U Dix; Jonathan Peter Little; John L K Kramer; Kathleen A Martin Ginis
Journal:  Front Rehabil Sci       Date:  2021-10-26

5.  Arm Crank and Wheelchair Ergometry Produce Similar Peak Oxygen Uptake but Different Work Economy Values in Individuals with Spinal Cord Injury.

Authors:  Tom Tørhaug; Berit Brurok; Jan Hoff; Jan Helgerud; Gunnar Leivseth
Journal:  Biomed Res Int       Date:  2016-04-10       Impact factor: 3.411

Review 6.  Peak oxygen uptake in Paralympic sitting sports: A systematic literature review, meta- and pooled-data analysis.

Authors:  Julia Kathrin Baumgart; Berit Brurok; Øyvind Sandbakk
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

7.  Comparison of peak oxygen uptake and exercise efficiency between upper-body poling and arm crank ergometry in trained paraplegic and able-bodied participants.

Authors:  Julia Kathrin Baumgart; Laura Gürtler; Gertjan Ettema; Øyvind Sandbakk
Journal:  Eur J Appl Physiol       Date:  2018-06-23       Impact factor: 3.078

8.  Intensity of physical activity as a percentage of peak oxygen uptake, heart rate and Borg RPE in motor-complete para- and tetraplegia.

Authors:  Tobias Holmlund; Elin Ekblom-Bak; Erika Franzén; Claes Hultling; Kerstin Wahman
Journal:  PLoS One       Date:  2019-12-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.